Drug Approval | March 11, 2023
USFDA completes inspection of Lupin’s Vizag facility
The inspection concluded with no observations
The inspection concluded with no observations
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Digital success is contingent on the way a company organizes itself around technology
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Rocuronium Bromide Injection is a neuromuscular blocking agent
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Subscribe To Our Newsletter & Stay Updated
